Published in Pharma Law Weekly, September 26th, 2006
"Strategies for improvement of blood flow by promoting new vessel growth in ischemic tissue are being developed. Recently, CEU imaging has been used to assess tissue perfusion in models of ischemia-related angiogenesis, growth-factor mediated angiogenesis, and tumor angiogenesis," scientists writing in the journal IEEE Transactions on Medical Imaging report.
"In these studies, microvascular flow is measured in order to assess the total impact of adaptations at different vascular levels. High-resolution methods for imaging larger vessels have been...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly